ENvue Medical, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $239.0K | $229.0K | $147.0K | $203.0K |
| Cost of Revenue | $88.0K | $88.0K | $49.0K | $93.0K |
| Gross Profit | $151.0K | $141.0K | $98.0K | $110.0K |
| Gross Margin | 63.2% | 61.6% | 66.7% | 54.2% |
| Operating Expenses | ||||
| Research & Development | $693.0K | $584.0K | $399.0K | $431.0K |
| SG&A Expense | $2.1M | $1.4M | $746.0K | $589.0K |
| Operating Income | $-3.1M | $-2.3M | $-1.4M | $-1.2M |
| Operating Margin | -1,293.3% | -1,011.4% | -968.7% | -596.6% |
| Interest Expense | $37.0K | $0 | $65.0K | $372.0K |
| Pretax Income | $-4.9M | $-2.7M | $-2.9M | $-2.6M |
| Income Tax Expense | $38.0K | $117.0K | $28.0K | $49.0K |
| Net Income | $-5.0M | $-2.8M | $-2.9M | $-2.6M |
| Net Margin | -2,077.4% | -1,236.2% | -1,961.9% | -1,303.9% |
| EPS (Basic) | $-0.05 | $-0.03 | $-0.04 | $-0.74 |
| EPS (Diluted) | $-0.05 | $-0.03 | $-0.04 | $-0.74 |
| Shares Outstanding (Basic) | 90.5M | 60.6M | 60.1M | 3.8M |
| Shares Outstanding (Diluted) | 90.5M | 60.6M | 60.1M | 3.8M |
| Dividends Per Share | — | — | — | — |